As AI systems have grown in sophistication, so has their capacity for deception, according to a new analysis from researchers at Massachusetts Institute of Technology (MIT). Dr Peter Park, an AI existential safety researcher at MIT and author of the research, tells Ian Sample about the different examples of deception he uncovered, and why they will be so difficult to tackle as long as AI remains a black box. Help support our independent journalism at theguardian.com/sciencepod
Wissenschaft & Technik
Science Weekly Folgen
Twice a week, the Guardian brings you the latest science and environment news
Folgen von Science Weekly
296 Folgen
-
Folge vom 14.05.2024Backstabbing, bluffing and playing dead: has AI learned to deceive?
-
Folge vom 09.05.2024How much protein is too much?Sales of cottage cheese are booming thanks to a boost from protein-hungry social media influencers. But do we really need all this extra protein? Madeleine Finlay speaks to Joanne Slavin, a professor of food science and nutrition at the University of Minnesota, to find out what exactly protein is doing in our bodies, and what happens to it when we consume it in excess. Help support our independent journalism at theguardian.com/sciencepod
-
Folge vom 07.05.2024Why are the world’s cities sinking?A study has found that more than two dozen US coastal cities are sinking by more than 2mm a year. It’s a similar picture across the world. Nearly half of China’s major cities, as well as places such as Tehran and Jakarta, are facing similar problems. These issues are compounded by sea level rises caused by global heating. Madeleine Finlay speaks to Prof Manoochehr Shirzaei of Virginia Tech University and Prof Robert Nicholls of the University of East Anglia to find out what’s making our cities sink and whether anything can be done to rescue them from the sea. Help support our independent journalism at theguardian.com/sciencepod
-
Folge vom 02.05.2024The extraordinary promise of personalised cancer vaccinesGlioblastomas are an extremely aggressive type of brain tumour, which is why the news this week of a vaccine that has shown promise in fighting them is so exciting. And this comes right off the back of the announcement of another trial of the world’s first personalised mRNA vaccine for melanoma, a kind of skin cancer. Ian Sample talks to Prof Alan Melcher of the Institute of Cancer Research about how these vaccines work and whether they could one day be used to target cancer before it is even detectable on scans. Help support our independent journalism at theguardian.com/sciencepod